Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Cancer. 2019 Oct 29;126(3):593–601. doi: 10.1002/cncr.32552

Figure 2: Association of hematopoietic stem cell transplantation and survival.

Figure 2:

(A) Five-year EFS rates for patients receiving HSCT in CR1 compared to no HSCT were 80±12% versus 68±10% (p=0.225); (B) five-year OS rates were 80±12% versus 75±9% (p=0.721).